JCPenney Gets $2.25...
Health Care: Health Services
AxoGen Inc (AXGN: OTC)
$4.50 -0.15 | -3.23%
05/23/13 - 11:15 AM ET
4.30K / 13.50K
Vol / Avg. Vol:4.50 / 4.65
Open / Prev. Close:4.50 - 4.50
Today's Range:2.06 - 6.25
52 Wk Range:70.37%
Performance YTD:TheStreet Rating:
Portfolios with AXGN
- Portfolio NameUser Type
Latest AXGN Headlines from TheStreet
- Healing Nerve Damage With Cadavers 04.29.13 | 12:04 pm
Press Releases for AXGN
- AxoGen, Inc. Reports Record 2012 Revenues - Business Wire 03.12.13 | 07:03 pm
- AxoGen, Inc. Announces Release Date Of 2012 Fourth Quarter & Year End Results And Conference Call - Business Wire 02.27.13 | 12:02 pm
- AxoGen To Present At Lazard Capital Markets Medical Technology Conference - Business Wire 02.13.13 | 03:02 pm
- AxoGen To Present At Noble Financial Equity Conference - Business Wire 01.15.13 | 07:01 am
- AxoGen, Inc. Announces Third Quarter 2012 Financial Results - Business Wire 11.07.12 | 08:11 am
- AxoGen, Inc. Announces Release Dates For 2012 Third Quarter Results And Conference Call - Business Wire 10.25.12 | 01:10 pm
- PDL BioPharma Completes Royalty Transaction With AxoGen - PR Newswire 10.09.12 | 04:10 pm
- AxoGen, Inc. Completes $20.8 Million Financing With PDL BioPharma, Inc. - Business Wire 10.09.12 | 04:10 pm
- AxoGen To Present At The Craig-Hallum Alpha Select Conference - Business Wire 09.20.12 | 10:09 am
- AxoGen To Present At Noble Financial Life Sciences Conference - Business Wire 09.11.12 | 12:09 pm
Partner Headlines for AXGN
